Functional characterization by genetic complementation of aroB-encoded dehydroquinate synthase from Mycobacterium tuberculosis H37Rv and its heterologous expression and purification. 2007

Jordana Dutra de Mendonça, and Fernanda Ely, and Mario Sergio Palma, and Jeverson Frazzon, and Luiz Augusto Basso, and Diógenes Santiago Santos
Centro de Pesquisas em Biologia Molecular e Funcional, Pontifícia Universidade Católica do Rio Grande do Sul, Av. Ipiranga, 6681, Tecnopuc, Prédio 92A, 90619-900, Porto Alegre, Rio Grande do Sul, Brazil.

The recent recrudescence of Mycobacterium tuberculosis infection and the emergence of multidrug-resistant strains have created an urgent need for new therapeutics against tuberculosis. The enzymes of the shikimate pathway are attractive drug targets because this route is absent in mammals and, in M. tuberculosis, it is essential for pathogen viability. This pathway leads to the biosynthesis of aromatic compounds, including aromatic amino acids, and it is found in plants, fungi, bacteria, and apicomplexan parasites. The aroB-encoded enzyme dehydroquinate synthase is the second enzyme of this pathway, and it catalyzes the cyclization of 3-deoxy-D-arabino-heptulosonate-7-phosphate in 3-dehydroquinate. Here we describe the PCR amplification and cloning of the aroB gene and the overexpression and purification of its product, dehydroquinate synthase, to homogeneity. In order to probe where the recombinant dehydroquinate synthase was active, genetic complementation studies were performed. The Escherichia coli AB2847 mutant was used to demonstrate that the plasmid construction was able to repair the mutants, allowing them to grow in minimal medium devoid of aromatic compound supplementation. In addition, homogeneous recombinant M. tuberculosis dehydroquinate synthase was active in the absence of other enzymes, showing that it is homomeric. These results will support the structural studies with M. tuberculosis dehydroquinate synthase that are essential for the rational design of antimycobacterial agents.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005816 Genetic Complementation Test A test used to determine whether or not complementation (compensation in the form of dominance) will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell. Allelism Test,Cis Test,Cis-Trans Test,Complementation Test,Trans Test,Allelism Tests,Cis Tests,Cis Trans Test,Cis-Trans Tests,Complementation Test, Genetic,Complementation Tests,Complementation Tests, Genetic,Genetic Complementation Tests,Trans Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial

Related Publications

Jordana Dutra de Mendonça, and Fernanda Ely, and Mario Sergio Palma, and Jeverson Frazzon, and Luiz Augusto Basso, and Diógenes Santiago Santos
August 1998, Biochemical Society transactions,
Jordana Dutra de Mendonça, and Fernanda Ely, and Mario Sergio Palma, and Jeverson Frazzon, and Luiz Augusto Basso, and Diógenes Santiago Santos
April 2006, Protein expression and purification,
Jordana Dutra de Mendonça, and Fernanda Ely, and Mario Sergio Palma, and Jeverson Frazzon, and Luiz Augusto Basso, and Diógenes Santiago Santos
March 2009, Protein expression and purification,
Jordana Dutra de Mendonça, and Fernanda Ely, and Mario Sergio Palma, and Jeverson Frazzon, and Luiz Augusto Basso, and Diógenes Santiago Santos
September 2012, Protein expression and purification,
Jordana Dutra de Mendonça, and Fernanda Ely, and Mario Sergio Palma, and Jeverson Frazzon, and Luiz Augusto Basso, and Diógenes Santiago Santos
November 2009, Current microbiology,
Jordana Dutra de Mendonça, and Fernanda Ely, and Mario Sergio Palma, and Jeverson Frazzon, and Luiz Augusto Basso, and Diógenes Santiago Santos
October 1997, Medical microbiology and immunology,
Jordana Dutra de Mendonça, and Fernanda Ely, and Mario Sergio Palma, and Jeverson Frazzon, and Luiz Augusto Basso, and Diógenes Santiago Santos
October 2006, FEMS microbiology letters,
Jordana Dutra de Mendonça, and Fernanda Ely, and Mario Sergio Palma, and Jeverson Frazzon, and Luiz Augusto Basso, and Diógenes Santiago Santos
October 1999, Canadian journal of microbiology,
Jordana Dutra de Mendonça, and Fernanda Ely, and Mario Sergio Palma, and Jeverson Frazzon, and Luiz Augusto Basso, and Diógenes Santiago Santos
August 2011, Applied biochemistry and biotechnology,
Jordana Dutra de Mendonça, and Fernanda Ely, and Mario Sergio Palma, and Jeverson Frazzon, and Luiz Augusto Basso, and Diógenes Santiago Santos
January 2011, Enzyme research,
Copied contents to your clipboard!